.png)
Medical Oxygen Concentrators Market has become one of the most essential segments of the global respiratory care industry. As chronic obstructive pulmonary disease (COPD), respiratory distress, and long-term oxygen therapy (LTOT) cases continue to rise, demand for both stationary and portable oxygen concentrators is increasing steadily worldwide. By 2025, healthcare systems are expected to see a significant shift from traditional cylinder-based delivery to modern, energy-efficient concentrators for both hospital and homecare use.
Major players such as ResMed (Inova Labs), Inogen Inc., Invacare Corporation, DeVilbiss Healthcare GmbH, Yuwell, Philips, and CAIRE Inc. continue to invest in smart oxygen concentrators that deliver quiet operation, longer battery life, and easy patient mobility — driving better compliance and quality of life.
The Medical Oxygen Concentrators Market was valued at USD 2,352.92 million in 2023 and is expected to reach USD 2,607.74 million in 2024, with growth projected to reach USD 5,937.25 million by 2032, reflecting a CAGR of 10.83% during the forecast period [2024-2032].
How Big is the Medical Oxygen Concentrators Market in 2025?
The global market for medical oxygen concentrators is estimated to see strong demand in 2025, driven by rising prevalence of COPD, an aging population, and improved homecare insurance coverage.
- Portable oxygen concentrators (POCs) now make up approximately 42% of total units used globally as patients increasingly favor mobility over stationary setups.
- Stationary units continue to hold about 58%, driven by hospital use, long-term homecare, and chronic therapy in patients who require high continuous flow.
By region:
- North America dominates with nearly 38% of global demand, fueled by widespread LTOT programs and reimbursement models that favor advanced POC adoption.
- Europe follows at around 28%, with mature markets like Germany, the UK, and France focusing on elderly care and aging-in-place initiatives.
- Asia Pacific contributes roughly 24%, the fastest-growing share as countries like China, India, and Southeast Asia scale up community respiratory care.
- Latin America and MEA together hold about 10%, offering significant room for expansion as healthcare infrastructure improves and awareness of home oxygen therapy grows.
Regional Insights
North America Detailed Insights
In the USA, homecare now represents over 75% of all medical oxygen concentrator sales, driven by rising COPD diagnoses, which affect more than 16 million Americans.
Around 48% of new units sold in 2025 are portable concentrators, allowing patients to maintain active lifestyles. Key states like California, Texas, and Florida have the largest installed base due to higher senior populations and well-established DME (durable medical equipment) supply networks.
Canada accounts for about 3% of the total market share, with provincial health plans increasingly funding portable concentrators for patients with moderate to severe hypoxia.
Europe Detailed Insights
Europe’s share sits at about 28%, with Germany leading regional demand at roughly 6%, thanks to its robust eldercare programs and advanced community care services.
The UK and France together contribute nearly 8%, where NHS-backed programs make home oxygen therapy accessible to thousands of patients each year.
Eastern Europe, including Poland and Romania, represents an emerging pocket, with affordable concentrator models gaining popularity as aging populations grow.
Asia Pacific Detailed Insights
Asia Pacific’s share approximately 24% is the fastest-growing region for oxygen concentrators.
China alone makes up about 8% of global demand, driven by rapidly increasing COPD cases among smokers and the elderly. The government’s push for more homecare solutions in Tier 1 and Tier 2 cities has fueled Yuwell’s growth and boosted local brands like Shenyang Canta Medical Tech. Co. Ltd.
India contributes about 5%, with new respiratory health programs bringing oxygen concentrators to smaller urban hospitals and rural clinics.
Japan, South Korea, and Australia together account for 6%, favoring premium portable units from brands like Teijin and Philips that emphasize quiet operation and patient comfort.
Latin America & MEA Detailed Insights
Latin America and the Middle East & Africa hold about 10% combined market share, but demand is steadily rising.
Brazil is the region’s largest buyer, accounting for approximately 4%, with new public health programs expanding home-based oxygen care.
Mexico, Argentina, and Chile together add another 2%, focused on community clinics and emergency preparedness.
In the MEA region, the UAE and Saudi Arabia are driving demand, with about 1% each, as private hospitals upgrade emergency oxygen therapy and homecare services grow.
Global Growth Insights unveils the top List Global Medical Oxygen Concentrators Companies:
| Company | Headquarters | CAGR (Past Year) | Revenue Trend |
|---|---|---|---|
| ResMed (Inova Labs) | USA | 4.9% | Strong US homecare demand & POC upgrades |
| DeVilbiss Healthcare GmbH | Germany | 3.8% | Stable EU sales, community care contracts |
| Inogen Inc. | USA | 5.4% | Rapid growth in direct-to-consumer POCs |
| Invacare Corporation | USA | 4.1% | Solid rental base & DME partnerships |
| Yuwell | China | 5.9% | Fast expansion in China & SE Asia markets |
| AirSep Corporation | USA | 4.2% | Strong institutional & emergency sales |
| Teijin Limited | Japan | 3.7% | Premium portable models, domestic focus |
| O2 Concepts LLC | USA | 4.5% | Smart connectivity driving POC demand |
| Koninklijke Philips N.V. | Netherlands | 4.6% | Integrated patient monitoring & oxygen care |
| NGK Spark Plug Co. Ltd. | Japan | 3.9% | Focus on oxygen sensors and device upgrades |
| NIDEK Medical Products Inc. | USA | 4.3% | Strong hospital-grade stationary sales |
| CAIRE Inc. | USA | 4.8% | Leading global supplier, new portable units |
| Shenyang Canta Medical Tech. Co. Ltd. | China | 5.7% | New growth in Asia Pacific and MEA |
FAQs — Global Medical Oxygen Concentrators Market
- Q1: What is driving the growth of portable oxygen concentrators in 2025?
A: Patient preference for mobility, longer battery life, and lightweight designs now account for over 42% of global demand. - Q2: Which region is seeing the fastest expansion?
A: Asia Pacific, contributing about 24% of the global market, driven by China, India, and Southeast Asia. - Q3: Which companies are leading?
A: ResMed, Inogen, Philips, and CAIRE Inc. lead with innovations in portable, smart-connected concentrators. - Q4: What trends will shape the next 5 years?
A: Home-based care growth, AI-enabled monitoring, compact designs, and insurance models supporting LTOT.